Kolexia
Ferrero Arthur
Ophtalmologie
Selarl Ferrero
Lavaur, France
47 Activités
437 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs de l'ovaire Cataracte Syndromes de l'oeil sec Aphakie après chirurgie de la cataracte Cardiopathies Membrane épirétinienne Dégénérescence maculaire Récidive tumorale locale Adénocarcinome

Industries

Novartis
10 collaboration(s)
Dernière en 2023
Thea
10 collaboration(s)
Dernière en 2023
Horus
4 collaboration(s)
Dernière en 2023
Abbvie
1 collaboration(s)
Dernière en 2023

Dernières activités

The carbon footprint and wastage of intravitreal injections.
Journal francais d'ophtalmologie   19 février 2024
Chirurgie de la cataracte : un bilan carbone qui donne le tournis
Acuité   17 mars 2023
The carbon footprint of cataract surgery in a French University Hospital.
Journal francais d'ophtalmologie   22 novembre 2021
Dry eye disease in the elderly in a French population-based study (the Montrachet study: Maculopathy, Optic Nerve, nuTRition, neurovAsCular and HEarT diseases): Prevalence and associated factors.
The ocular surface   20 septembre 2017
Could 24-S-hydroxycholesterol play a role in Müller glial cell's membrane dynamics in the rat
Abstracts from the 2016 European Association for Vision and Eye Research Conference   14 septembre 2016
One year results of the follow-up of patients with asymptomatic idiopathic epiretinal membrane
Abstracts from the 2014 European Association for Vision and Eye Research Conference   20 août 2014
Health-related quality of life in recurrent platinum-sensitive ovarian cancer--results from the CALYPSO trial.
Annals of oncology : official journal of the European Society for Medical Oncology   30 janvier 2012
CA-125 can be part of the tumour evaluation criteria in ovarian cancer trials: experience of the GCIG CALYPSO trial.
British journal of cancer   12 janvier 2012
Carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in partially platinum-sensitive ovarian cancer patients: results from a subset analysis of the CALYPSO phase III trial.
Annals of oncology : official journal of the European Society for Medical Oncology   05 octobre 2011
Prognostic nomogram to predict progression-free survival in patients with platinum-sensitive recurrent ovarian cancer.
British journal of cancer   13 septembre 2011